Home » Stocks » Guardion Health Sciences

Guardion Health Sciences, Inc. (GHSI)

Stock Price: $0.432 USD -0.005 (-1.05%)
Updated Jul 9, 2020 9:38 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 36.95M
Revenue (ttm) 906,122
Net Income (ttm) -11.84M
Shares Out 85.62M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 9, 2020
Last Price $0.432
Previous Close $0.436
Change ($) -0.005
Change (%) -1.05%
Day's Open 0.430
Day's Range 0.426 - 0.435
Day's Volume 307,393
52-Week Range 0.165 - 3.050

More Stats

Market Cap 36.95M
Enterprise Value 24.05M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 85.62M
Float 72.63M
EPS (basic) -0.28
EPS (diluted) -0.23
FCF / Share -0.09
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.23M
Short Ratio 0.40
Short % of Float 4.08%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 40.78
PB Ratio 2.63
Revenue 906,122
Operating Income -11.65M
Net Income -11.84M
Free Cash Flow -7.39M
Net Cash 12.90M
Net Cash / Share 0.15
Gross Margin 61.98%
Operating Margin -1,285.47%
Profit Margin -1,306.30%
FCF Margin -815.16%
ROA -64.25%
ROE -151.53%
ROIC -1,049.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue0.900.940.440.140.11
Revenue Growth-4.16%115.42%210.11%25.01%-
Gross Profit0.560.540.260.070.06
Operating Income-10.50-6.14-5.28-3.95-6.39
Net Income-10.88-7.77-5.31-5.75-8.84
Shares Outstanding36.4720.1913.9310.908.20
Earnings Per Share-0.30-0.38-0.45-0.60-1.08
Operating Cash Flow-6.03-4.17-3.40-1.65-1.14
Capital Expenditures-0.17-0.31-0.04--
Free Cash Flow-6.20-4.48-3.44-1.66-1.14
Cash & Equivalents11.130.684.750.060.01
Total Debt--0.030.070.77
Net Cash / Debt11.130.684.72-0.01-0.76
Assets12.883.687.370.260.25
Liabilities0.840.500.500.611.47
Book Value12.033.196.87-0.35-1.23
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Guardion Health Sciences, Inc.
Country United States
Employees 21
CEO David W. Evans

Stock Information

Ticker Symbol GHSI
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: GHSI

Description

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Medical Devices. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. The Medical Devices segment offers VectorVision, which develops, manufactures, and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing; CSV-1000, an instrument for contrast sensitivity, glare sensitivity, low contrast acuity, and early treatment diabetic retinopathy; CSV-2000, a digital standardized contrast sensitivity testing device; and MapcatSF, a medical device that measures the macular pigment optical density. The company distributes its products through sales force, as well as through its guardionhealth.com Website. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.